Generic Drug Application Yields Patent Complaint In Delaware Federal Court
WILMINGTON, Del. — Amgen Inc., maker of the chronic heart failure (CHF) drug Corlanor, levied allegations of patent infringement against the filers of an abbreviated new drug application (ANDA) in a...To view the full article, register now.
Already a subscriber? Click here to view full article